Skip to main content
. Author manuscript; available in PMC: 2023 Jan 1.
Published in final edited form as: J Minim Invasive Gynecol. 2021 Jul 13;29(1):119–127. doi: 10.1016/j.jmig.2021.07.004

TABLE 2.

Association between use of hysteroscopy and likelihood of preoperative diagnosis of leiomyosarcoma, after adjusting for other patient and tumor characteristics

Patient and Tumor Characteristics Adjusted Risk Ratio 95% Confidence Interval
Type of endometrial sampling
 With hysteroscopy 3.03 (1.43, 6.42)
 Without hysteroscopy Reference
Age
 18–54 years Reference
 ≥55 years 1.00 (0.64, 1.54)
Race/Ethnicity
 Non-Hispanic White 1.00 (0.66, 1.50)
 Other/Unknown Reference
Cancer stage
 Localized 0.50 (0.28, 0.89)
 Regional 0.60 (0.35, 1.05)
 Distant Reference
Cancer grade
 1–3 Reference
 4 1.35 (0.90, 2.03)
 Unknown 1.06 (0.61, 1.84)
Tumor size
 <8 cm Reference
 8–11 cm 0.82 (0.49, 1.38)
 >11 cm 0.54 (0.30, 0.99)
 Unknown 1.36 (0.82, 2.24)
Presence of a diagnosis code for leiomyoma
 Yes 0.92 (0.62, 1.36)
 No Reference
Postmenopausal bleeding
 Yes 1.13 (0.70, 1.81)
 No Reference
Premenopausal menorrhagia/frequent Menstruation
 Yes 0.78 (0.42, 1.47)
 No Reference